In cardiovascular protection, it attenuates myocardial hypertrophy by inhibiting HDAC2-KLF4 signaling, blocks STAT3-mediated cardiac fibroblast activation, and restores cardiac metabolism through EGFR/IKBβ pathway activation. This evidence concerns the gene KLF4 and cardiac hypertrophy.